- Paxil: The Truth Revealed by Alison Bass
- Recalls of the Week
- Recalls of the Week
- Going Solo - I'm Defying Gravity
- Recalls of the Week (maybe two weeks)..
- The New York Observer Finds My Son - The Whirlwind Continues
- New York Times Publishes Son's Letter
- Birmingham News Reports Two People Injured in SUV Rollover on I-59
- Recalls of the Week
- Bayer Pulls Trasylol (Aprotinin) Completely From The Market
- Digitek Recall Still A Mystery
- Recalls of the Week
- Drug and Device Law - A Must for ALL Drug Lawyers
- Baxter Says Its Taken No Legal Hit from Heparin
- Recalls of the Week
- FDA Thinks FDA Contamination May Have Been Deliberate
- Recalls of the Week
- New York Times Addresses Concerns Raised About "Ghostwriting" of Drug Studies
- Ford Settles Class Action Regarding Ford Explorers and Rollovers
- Hillbilly Redneck Teeth Recalled
- AP Reports: Another Secret of the Pharmaceutical World to be Revealed: The Drs. Who Take Money and Trips from Big Pharma
- New York Times and Reader's Digest Address Problem of Preemption in Drug Cases, Part III
- Vytorin--Merck, Why Did You Wait So Long!?!
- New York Times and Reader's Digest Address Problem of Preemption in Drug Cases, Part II
- New York Times and Reader's Digest Address Problem of Preemption in Drug Cases, Part I
- Study Indicates Clinical Trials for Drugs Don't Include the Right People
- Crestor Study Ended Due to Good Results
- Business Week Magazine Addresses Federal Preemption Concern
- New York Times Addresses Preemption Concerns Led to Alaska Settlement of Zyprexa Claim
- Preemption and the Supreme Court: Our Rights Are Being Taken Away And Nobody Knows
- FDA Reviewing Potential Cancer Risk from Regranx, an Ulcer Drug
- FDA Warns About Suicidality with use of Singulair
- General Motors Settles Class Action regarding Dex-Cool Coolant
- FDA Still Sitting on the Trasylol Issue
- Products Liability Lawyer Begins His Push Into The Blogging World